Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Small Cell”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT04164745
What this trial is testing

Efficacy and Safety Study of Anlotinib With Pembrolizumab in Adults With Programmed Cell Death-Ligand 1 (PD-L1)-Positive Treatment-naïve Non-small Cell Lung Cancer

Who this might be right for
NSCLC
Peking Union Medical College Hospital 49
Testing effectiveness (Phase 2)Study completedNCT04677595
What this trial is testing

Study of Capmatinib in Chinese Adult Patients With Advanced Non-small Cell Lung Cancer Harboring MET Exon 14 Skipping Mutation

Who this might be right for
Non-Small Cell Lung Cancer (NSCLC)
Novartis Pharmaceuticals 36
Not applicableLooking for participantsNCT07837739
What this trial is testing

Adjuvant EGFR-TKI Therapy After Surgery for EGFR-Mutant High-Risk Stage IA2-IIB NSCLC

Who this might be right for
Non-Small Cell Lung Cancer
Tongji Hospital 100
Testing effectiveness (Phase 2)UnknownNCT01965275
What this trial is testing

High-Dose,Pulsatile Erlotinib/Gefitinib for Advanced NSCLC Patients After Failure of Standard Dose EGFR-TKIs

Who this might be right for
Self EfficacyDrug Toxicity
Anhui Medical University 20
Large-scale testing (Phase 3)Not Yet RecruitingNCT07633873
What this trial is testing

SYS6010 Combined With Enlonstobart Versus Immunotherapy+ Platinum-based Chemotherapy for Patients With PD-L1-Positive Locally Advanced or Metastatic NSCLC（SYNSTAR 04）

Who this might be right for
Non-Small Cell Lung Cancer
CSPC Megalith Biopharmaceutical Co.,Ltd. 500
Large-scale testing (Phase 3)Study completedNCT02486354
What this trial is testing

Icotinib in Advanced Metastatic Patients With NSCLC Previously Treated With Chemotherapy

Who this might be right for
Non-small Cell Lung Cancer
Betta Pharmaceuticals Co., Ltd. 128
Not applicableStudy completedNCT05512429
What this trial is testing

Prognostic Value of Body Composition in Lung Cancer

Who this might be right for
Body Composition and Non-small Cell Lung Cancer
Marmara University 83
Large-scale testing (Phase 3)Study completedNCT00006229
What this trial is testing

Paclitaxel + Carboplatin With/ut BMS-275291 in Advanced or Metastatic Non-small Cell Lung Cancer

Who this might be right for
Lung Cancer
NCIC Clinical Trials Group 774
Not applicableStudy completedNCT00919269
What this trial is testing

Collecting and Storing Tissue, Blood, and Bone Marrow Samples From Patients With Rhabdomyosarcoma or Other Soft Tissue Sarcoma

Who this might be right for
Adult RhabdomyosarcomaChildhood Desmoplastic Small Round Cell TumorChordoma+13 more
Children's Oncology Group 150
Testing effectiveness (Phase 2)Looking for participantsNCT06616766
What this trial is testing

A Phase 1/2, Open-label, Multicenter, FIH Study to Evaluate Safety, Tolerability, PK and Anti-tumor Activity of YH42946

Who this might be right for
NSCLC (Non-small Cell Lung Cancer)Solid Tumor
Yuhan Corporation 201
Early research (Phase 1)Study completedNCT00128622
What this trial is testing

Denileukin Diftitox Followed by Vaccine Therapy in Treating Patients With Metastatic Cancer

Who this might be right for
Breast CancerColorectal CancerLung Cancer+2 more
H. Kim Lyerly 24
Testing effectiveness (Phase 2)Study completedNCT01561456
What this trial is testing

Study of AXL1717 Compared to Docetaxel to Treat Squamous Cell Carcinoma or Adenocarcinoma of the Lung

Who this might be right for
Non-small-cell Lung CancerSquamous Cell CarcinomaAdenocarcinoma of the Lung
Axelar AB 100
Early research (Phase 1)Active Not RecruitingNCT05334329
What this trial is testing

Genetically Engineered Natural Killer (NK) Cells With or Without Atezolizumab for the Treatment of Non-small Cell Lung Cancer Previously Treated With PD-1 and/or PD-L1 Immune Checkpoint Inhibitors

Who this might be right for
Advanced Lung Non-Small Cell CarcinomaMetastatic Lung Non-Small Cell CarcinomaRecurrent Lung Non-Small Cell Carcinoma+8 more
University of California, Irvine 6
Early research (Phase 1)UnknownNCT03076372
What this trial is testing

A Study Evaluating MM-310 in Patients With Solid Tumors

Who this might be right for
Solid TumorsUrothelial CarcinomaGastric Carcinoma+9 more
Merrimack Pharmaceuticals 34
Testing effectiveness (Phase 2)Ended earlyNCT03366675
What this trial is testing

AZD 2811 Monotherapy in Relapsed Small Cell Lung Cancer Patients [SUKSES-N3]

Who this might be right for
Small Cell Lung Cancer
Samsung Medical Center 15
Large-scale testing (Phase 3)Looking for participantsNCT06216301
What this trial is testing

LUNAR-2: TTFields With Pembrolizumab + Platinum-based Chemotherapy for Metastatic NSCLC

Who this might be right for
Metastatic Non-small Cell Lung Cancer
NovoCure GmbH 734
Large-scale testing (Phase 3)Study completedNCT02284139
What this trial is testing

Pilot Trial of EGF Ointment for the Patients With EGFR-i Related Skin Side Effects

Who this might be right for
Non-small Cell Lung CancerPancreatic CancerColorectal Cancer
Dong-A University Hospital 90
Early research (Phase 1)Looking for participantsNCT07225439
What this trial is testing

Rituximab (Rtx) + Tafasitamab in Combination With Allogeneic NK Cells for Treatment of Relapsed/Refractory (r/r) B-cell Non-Hodgkin Lymphoma (NHL)

Who this might be right for
Non Hodgkin LymphomaB-cell Non Hodgkin LymphomaDiffuse Large B Cell Lymphoma+7 more
Paolo Caimi, MD 15
Testing effectiveness (Phase 2)Active Not RecruitingNCT03600701
What this trial is testing

Atezolizumab and Cobimetinib in Treating Patients With Metastatic, Recurrent, or Refractory Non-small Cell Lung Cancer

Who this might be right for
Metastatic Lung Non-Small Cell CarcinomaRecurrent Lung Non-Small Cell CarcinomaRefractory Lung Non-Small Cell Carcinoma+1 more
National Cancer Institute (NCI) 53
Not applicableStudy completedNCT02458651
What this trial is testing

Disease Characteristics, Treatment Patterns and Clinical Outcomes in Patients With Newly Diagnosed Unresectable Stage IIIB/IV Non-Small Cell Lung Cancer (NSCLC) in China

Who this might be right for
Non-Small Cell Lung Cancer, Lung Cancer, Cancer
Hoffmann-La Roche 1,378
Next Page